Amna Ghith

Dr. Amna Ghith

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
AGAmna Ghith
Amna Ghith
KYKhairia M. Youssef
Khairia M. Youssef
NINasser Ismail
Nasser Ismail
KAKhaled A. M. Abouzid
Khaled A. M. Abouzid

13 October 2017 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
AGAmna Ghith
Amna Ghith
NINasser Ismail
Nasser Ismail
KYKhairia Youssef
Khairia Youssef
KAKhaled A.M. Abouzid
Khaled A.M. Abouzid

27 June 2023 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
DDDaniel Zocchi Doherty
Daniel Zocchi Doherty
AGAmna Ghith
Amna Ghith
AHAva Ho
Ava Ho
JVJames De Voss
James De Voss
SBStephen Bell
Stephen Bell
Cholesterol catabolism is an important survival mechanism for the pathogenic Mycobacterium tuberculosis . Here we demonstrate that the CYP125 family of cytochrome P450 enzymes can catalyse the oxidation of phytosterols as well as cholesterol.

24 February 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
AGAmna Ghith
Amna Ghith
Reza MalekiReza Maleki
Reza Maleki
LGLuke E Grzeskowiak
Luke E Grzeskowiak
LALisa H Amir
Lisa H Amir
Wendy IngmanWendy Ingman
Wendy Ingman
Breastmilk is a complex biological fluid containing over a thousand bioactive proteins, lipids, cells and small molecules that provide nutrition and immunological protection for infants and children. The composition of breastmilk is unique to each individual and can also vary within individuals according to breastfeeding duration, maternal health, time of day, and other factors. As such, the composition of breastmilk can be considered a “fingerprint” that could be interrogated to identify biomarkers of breast health and disease. However, accurate quantification of bioactive components in breastmilk remains a significant challenge. Approaches such as immunoassays and mass spectrometry have been largely applied to study blood or other biological fluids and require validation and optimisation before these techniques can be used to accurately quantify bioactive compounds in breastmilk. Development of protocols specific to breastmilk should be carried out with high precision, confidence, and sensitivity. This review explores the challenges and opportunities associated with different techniques for quantification of breastmilk bioactive components.

28 March 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SHSoha R. Abd El Hadi
Soha R. Abd El Hadi
MEManar A. Eldinary
Manar A. Eldinary
AGAmna Ghith
Amna Ghith
HHHesham Haffez
Hesham Haffez
ASAya Salman
Aya Salman
GSGhadir A. Sayed
Ghadir A. Sayed
Discovery of new PIM-1 inhibitors with the 4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile scaffold with S -arylamide hybrids.

23 September 2024 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
PDF file
Reza MalekiReza Maleki
Reza Maleki
AGAmna Ghith
Amna Ghith
HHHanieh Heydarlou
Hanieh Heydarlou
LGLuke E Grzeskowiak
Luke E Grzeskowiak
Wendy IngmanWendy Ingman
Wendy Ingman
Background: Lactation is associated with long-term reduced risk of breast cancer. However, there is a transient increased risk of breast cancer in the 5 to 10 years postpartum and this is associated with a high incidence of metastasis and mortality. Breastmilk is a physiological fluid secreted by the mammary glands intimately connected with breast cells and the microenvironment that may affect postpartum breast cancer development and progression. This study aims to investigate the effect of breastmilk on interactions between breast cancer cells and macrophages in vitro. Methods: Human breastmilk from healthy donors (n = 7) was pooled and incubated with breast cancer (MCF-7 and MDA-MB-231) and macrophage (RAW264.7) cell lines to assess cell proliferation, viability, migration, and expression of key genes associated with epithelial-mesenchymal transition (EMT) and macrophage phenotype. Indirect co-culture studies assessed the effect of breastmilk on interactions between breast cancer cells and macrophages. Results: Breastmilk increased the proliferation and viability of breast cancer cells, reduced EMT markers, and reduced cell migration in MDA-MB-231 cells. Breastmilk decreased mRNA expression of interleukin 1B (IL1B) and interleukin 10 (IL10) in macrophages. Reduced EMT marker expression was observed in breast cancer cells co-cultured with macrophages pre-treated with breastmilk. Macrophages co-cultured with breast cancer cells pre-treated with breastmilk exhibited increased expression of a pro-inflammatory cytokine tumor necrosis factor A (TNFA) and pro-inflammatory nitric oxide synthase 2 (NOS2), and reduced expression of cytokines IL10 and transforming growth factor B1 (TGFB1) which are associated with the alternatively-activated macrophage phenotype. Conclusions: Breastmilk has the potential to promote breast cancer proliferation, however, it can also reduce breast cancer progression through inhibition of breast cancer cell migration and regulation of macrophage polarisation. These findings suggest that breastmilk has potential to shape the tumour microenvironment in postpartum breast cancer.